Role of leucine-rich α-2-glycoprotein in Taiwanese patients with inflammatory bowel disease as a predictive biomarker for endoscopic activity

Read full text
Authors: Yun-Chu Chen, Meng‐Tzu Weng, Feng-Pai Tsai, Zhi-Che Chen, Hsin-Yun Wu, Chien‐Chih Tung, Chunying Wang, Shu-Chen Wei
Cited by: 1
References: 30

Abstract

BACKGROUND Endoscopy is the gold standard for examining inflammatory bowel disease (IBD), and fecal calprotectin (FC) is a widely used surrogate marker for IBD. However, both methods are considered unpleasant by patients because of their invasiveness and inconvenience. Leucine-rich α-2-glycoprotein (LRG) is a novel serum biomarker that has been previously studied only in Japanese populations. AIM To evaluate the predictive utility of LRG in a Taiwanese cohort. METHODS Patients with IBD were prospectively enrolled between 2022 and 2024. Serum and stool samples were collected within 1 month of endoscopy, and patient albumin, hemoglobin (Hb), and C-reactive protein (CRP) levels were measured. Active endoscopic disease was defined as a Mayo endoscopic subscore ≥ 2 for ulcerative colitis (UC) or a Simple Endoscopic Score for Crohn’s Disease ≥ 6 for Crohn’s disease (CD). Correlations and diagnostic performance of biomarkers were analyzed. RESULTS A total of 203 patients (100 with UC and 103 with CD) were enrolled. LRG was positively correlated with FC and CRP but negatively correlated with Hb and albumin (P < 0.05). In UC, the area under the curves (AUCs) for CRP, LRG, and FC in predicting endoscopic activity were 0.54, 0.56, and 0.77, respectively (P < 0.001). In CD, the corresponding AUCs were 0.69, 0.60, and 0.72 (P > 0.05). The addition of LRG modestly improved predictive ability for endoscopic activity in patients with UC. In patients with UC with low CRP levels, combining CRP, Hb, and LRG significantly improved diagnostic accuracy (AUC increased from 0.60 to 0.76, P < 0.05), achieving a performance comparable to, though slightly lower than, that of FC (AUC: 0.78). CONCLUSION LRG may serve as a supportive biomarker, particularly in combination with other markers, for assessing disease activity in Taiwanese patients with IBD. In patients with UC with normal CRP levels, adding LRG and Hb could enhance the predictive accuracy for endoscopic activity to nearly that of FC.

Fields of Study & Subjects

Clusterin in disease pathology Inflammatory Bowel Disease Inflammation biomarkers and pathways

Publication details

Journal / source
World Journal of Gastroenterology
Publisher
Baishideng Publishing Group Inc.
Volume
32
Issue
3
Pages
114677–114677
Publication date
16 January 2026
Language
EN